Gimeracil
Specifications
103766-25-2CAS Number
870-589-4EC Number
5-chloro-4-hydroxy-1H-pyridin-2-oneIUPAC Name
C5H4ClNO2Chemical Formula
145.54 g/molMolecular Weight
Gimeracil; 103766-25-2; 5-Chloro-2,4-dihydroxypyridine; gimestat; 5-Chloro-2,4-pyridinediol; DTXSID8046799; Gimeracilo; UA8SE1325T; DTXCID6026799; TEYSUNO COMPONENT GIMERACIL; CDHP; gimeracilum; Chlorodihydroxypyridine; RefChem:639937; 5-chloropyridine-2,4-diol; 5-Chloro-4-hydroxy-2(1H)-pyridinone; 5-Chloro-4-hydroxy-1H-pyridin-2-one; 5-CHLORO-4-HYDROXYPYRIDIN-2(1H)-ONE; Gimeracil [INN]; 5-Chloro-4-hydroxy-2(1H)-pyridone; 2(1H)-Pyridinone, 5-chloro-4-hydroxy-; MFCD08458352; 5-chloro-2-hydroxypyridin-4(1H)-one; 5-CHLORO-4-HYDROXY-2-PYRIDONE; 5-CHLORO-4-HYDROXY-1,2-DIHYDROPYRIDIN-2-ONE; NCGC00181011-01; 1349387-07-0; Cdhp compound; 5-chloro-2-hydroxy-1H-pyridin-4-one; CAS-103766-25-2; UNII-UA8SE1325T; Gimeracil (JAN/INN); GIMERACIL [JAN]; GIMERACIL [MI]; GIMERACIL [WHO-DD]; GIMERACIL [EMA EPAR]; SCHEMBL124438; SCHEMBL459858; Gimeracil - Bio-X trade mark; Ts-1 (TN); orb1227088; orb1310100; orb3141399; SCHEMBL4940676; CHEMBL1730601; Gimeracil, >=98% (HPLC); CHEBI:31652; HMS3655B15; HMS5080J21; JXB97929; Tox21_112661; AC-475; EBC-17025; MFCD00923843; AKOS006346735; AKOS015891515; AKOS026749993; Tox21_112661_1; CCG-266172; CS-1822; DB09257; FC15749; KS-5133; 5-Chloro-4-hydroxypyridine-2(1H)-one; NCGC00181011-02; BG300043; HY-17469; SY029154; C2243; NS00040966; S2055; SW219483-1; T0987; D01846; SBI-0654130.0001; 5-CHLORO-4-HYDROXY PYRIDINE-2(1H)-ONE; AB01566858_01; EN300-3186161; F857700; SR-01000945072; SR-01000945072-1; BRD-K35687421-001-02-5; BRD-K35687421-001-03-3; Q22075887; Z1201624655Synonyms